BICYCLIC 1, 2, 4-OXADIAZOLES DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS
申请人:Allergan, Inc.
公开号:US20140100197A1
公开(公告)日:2014-04-10
The present invention relates to bicyclic aryl 1,2,4-oxadiazoles derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
本发明涉及双环芳基1,2,4-噁二唑衍生物,其制备方法,含有它们的药物组合物以及它们作为调节鞘氨醇-1-磷酸受体的药物的用途。